Ovarian Cancer Research Alliance Welcomes Largest Cohort of Advocate Leaders in Organizational History 

Ovarian Cancer Research Alliance is pleased to welcome our 2024 cohort of Advocate Leaders, the biggest ever for our organization with a total of 125 participants. This year’s group, which comprises 43 new participants and 82 returnees, represents 39 states, including the new additions of Nevada and North Dakota.

“We are so excited to get to work with this new class of Advocate Leaders,” said OCRA’s Vice President of Policy, Chad Ramsey. “Not only is this our largest group in the program’s history, but the diverse skills, experience and knowledge that they possess is impressive.”

This year’s Advocate Leaders will be working to increase federal support for ovarian cancer research and education programs, reauthorize and expand Johanna’s Law (which focuses on raising awareness about all gynecologic cancers), improve access to genetic testing, and identify additional legislative champions in the U.S. House and Senate. They will concentrate on specific areas of advocacy through their work on different committees within the program that target critical topics including cost of care and treatment, health disparities, and clinical trials.  

All Advocate Leaders receive training from OCRA’s staff on the legislative issues important to the ovarian and gynecologic cancer community, as well as how to effectively communicate with elected officials and their staff.

“Legislative victories don’t come without hard work by talented advocates,” noted Chad. “The people who are a part of the Advocate Leaders program are speaking on behalf of ovarian cancer patients everywhere. OCRA is committed to making sure they have the best possible chance to be effective and make a real difference.”

Learn more about getting involved with OCRA’s advocacy efforts.